BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 50 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $175,500 | -66.9% | 97,500 | -68.9% | 0.05% | -65.7% |
| Q3 2022 | $530,000 | -31.3% | 313,600 | 0.0% | 0.14% | -31.9% |
| Q2 2022 | $771,000 | -11.3% | 313,600 | 0.0% | 0.21% | -7.1% |
| Q1 2022 | $869,000 | -20.9% | 313,600 | +52.2% | 0.23% | -18.1% |
| Q4 2021 | $1,099,000 | – | 206,100 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 634,191 | $1,820,128 | 2.14% |
| NEA Management Company, LLC | 4,448,757 | $12,767,933 | 0.99% |
| CHI Advisors LLC | 720,000 | $2,066,400 | 0.82% |
| Bellevue Group AG | 8,135,839 | $23,349,858 | 0.38% |
| Parkman Healthcare Partners LLC | 520,587 | $1,494,085 | 0.27% |
| Artal Group S.A. | 2,046,517 | $5,874 | 0.25% |
| RA Capital Management | 3,525,754 | $10,118,914 | 0.20% |
| Ikarian Capital, LLC | 555,572 | $1,594,492 | 0.19% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,148,000 | 0.16% |
| Newtyn Management, LLC | 205,000 | $588,350 | 0.14% |